434 related articles for article (PubMed ID: 25511514)
1. Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer Chemotherapeutics.
Arkwright RT; Deshmukh R; Adapa N; Stevens R; Zonder E; Zhang Z; Farshi P; Ahmed RS; El-Banna HA; Chan TH; Dou QP
Anticancer Agents Med Chem; 2015; 15(5):657-71. PubMed ID: 25511514
[TBL] [Abstract][Full Text] [Related]
2. Natural activators of adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) and their pharmacological activities.
Vazirian M; Nabavi SM; Jafari S; Manayi A
Food Chem Toxicol; 2018 Dec; 122():69-79. PubMed ID: 30290216
[TBL] [Abstract][Full Text] [Related]
3. Development of Potent Adenosine Monophosphate Activated Protein Kinase (AMPK) Activators.
Dokla EM; Fang CS; Lai PT; Kulp SK; Serya RA; Ismail NS; Abouzid KA; Chen CS
ChemMedChem; 2015 Nov; 10(11):1915-23. PubMed ID: 26350292
[TBL] [Abstract][Full Text] [Related]
4. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
[TBL] [Abstract][Full Text] [Related]
5. Anticancer properties of novel pyrazole-containing biguanide derivatives with activating the adenosine monophosphate-activated protein kinase signaling pathway.
Zhou S; Xu L; Cao M; Wang Z; Xiao D; Xu S; Deng J; Hu X; He C; Tao T; Wang W; Guan A; Yang X
Arch Pharm (Weinheim); 2019 Sep; 352(9):e1900075. PubMed ID: 31339189
[TBL] [Abstract][Full Text] [Related]
6. Metformin: Insights into its anticancer potential with special reference to AMPK dependent and independent pathways.
Ikhlas S; Ahmad M
Life Sci; 2017 Sep; 185():53-62. PubMed ID: 28755883
[TBL] [Abstract][Full Text] [Related]
7. In silico Analysis of AMP-activated Protein Kinase and Ligand-based Virtual Screening for Identification of Novel AMPK Activators.
Ghaffar A; Batool S; Mushtaq G; Kamal MA
Curr Comput Aided Drug Des; 2017; 13(3):222-233. PubMed ID: 28294049
[TBL] [Abstract][Full Text] [Related]
8. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
[TBL] [Abstract][Full Text] [Related]
9. Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells.
Kang JI; Hong JY; Lee HJ; Bae SY; Jung C; Park HJ; Lee SK
PLoS One; 2015; 10(12):e0144368. PubMed ID: 26656173
[TBL] [Abstract][Full Text] [Related]
10. Selective AMPK activator leads to unfolded protein response downregulation and induces breast cancer cell death and autophagy.
Nascimento Mello AL; Sagrillo FS; de Souza AG; Costa ARP; Campos VR; Cunha AC; Imbroisi Filho R; da Costa Santos Boechat F; Sola-Penna M; de Souza MCBV; Zancan P
Life Sci; 2021 Jul; 276():119470. PubMed ID: 33831423
[TBL] [Abstract][Full Text] [Related]
11. Anthocyanins are novel AMPKα1 stimulators that suppress tumor growth by inhibiting mTOR phosphorylation.
Lee YK; Lee WS; Kim GS; Park OJ
Oncol Rep; 2010 Dec; 24(6):1471-7. PubMed ID: 21042741
[TBL] [Abstract][Full Text] [Related]
12. Combined cancer therapy with non-conventional drugs: all roads lead to AMPK.
Chen S; Zhu X; Lai X; Xiao T; Wen A; Zhang J
Mini Rev Med Chem; 2014; 14(8):642-54. PubMed ID: 25138094
[TBL] [Abstract][Full Text] [Related]
13. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
[TBL] [Abstract][Full Text] [Related]
14. Recent progress in the identification of adenosine monophosphate-activated protein kinase (AMPK) activators.
Cameron KO; Kurumbail RG
Bioorg Med Chem Lett; 2016 Nov; 26(21):5139-5148. PubMed ID: 27727125
[TBL] [Abstract][Full Text] [Related]
15. Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells.
Cai H; Zhang Y; Han TK; Everett RS; Thakker DR
Int J Cancer; 2016 May; 138(9):2281-92. PubMed ID: 26669511
[TBL] [Abstract][Full Text] [Related]
16. Novel synthetic baicalein derivatives caused apoptosis and activated AMP-activated protein kinase in human tumor cells.
Ding D; Zhang B; Meng T; Ma Y; Wang X; Peng H; Shen J
Org Biomol Chem; 2011 Nov; 9(21):7287-91. PubMed ID: 21901221
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
[TBL] [Abstract][Full Text] [Related]
18. Promise and challenges for direct small molecule AMPK activators.
Olivier S; Foretz M; Viollet B
Biochem Pharmacol; 2018 Jul; 153():147-158. PubMed ID: 29408352
[TBL] [Abstract][Full Text] [Related]
19. Direct and indirect activation of eukaryotic elongation factor 2 kinase by AMP-activated protein kinase.
Johanns M; Pyr Dit Ruys S; Houddane A; Vertommen D; Herinckx G; Hue L; Proud CG; Rider MH
Cell Signal; 2017 Aug; 36():212-221. PubMed ID: 28502587
[TBL] [Abstract][Full Text] [Related]
20. Cryptotanshinone induces G1 cell cycle arrest and autophagic cell death by activating the AMP-activated protein kinase signal pathway in HepG2 hepatoma.
Park IJ; Yang WK; Nam SH; Hong J; Yang KR; Kim J; Kim SS; Choe W; Kang I; Ha J
Apoptosis; 2014 Apr; 19(4):615-28. PubMed ID: 24173372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]